These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3850 related articles for article (PubMed ID: 7489563)

  • 21. Identification of a mutated receptor-like protein tyrosine phosphatase kappa as a novel, class II HLA-restricted melanoma antigen.
    Novellino L; Renkvist N; Rini F; Mazzocchi A; Rivoltini L; Greco A; Deho P; Squarcina P; Robbins PF; Parmiani G; Castelli C
    J Immunol; 2003 Jun; 170(12):6363-70. PubMed ID: 12794170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
    Sensi M; Salvi S; Castelli C; Maccalli C; Mazzocchi A; Mortarini R; Nicolini G; Herlyn M; Parmiani G; Anichini A
    J Exp Med; 1993 Oct; 178(4):1231-46. PubMed ID: 8376931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
    Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
    Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-specific T-cell clones recognize different protein determinants of autologous human malignant melanoma cells.
    Notter M; Schirrmacher V
    Int J Cancer; 1990 May; 45(5):834-41. PubMed ID: 2159436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of cellular immune response against autologous human melanoma. I. Evidence for cell-mediated suppression of in vitro cytotoxic immune response.
    Mukherji B; Wilhelm SA; Guha A; Ergin MT
    J Immunol; 1986 Mar; 136(5):1888-92. PubMed ID: 2419418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of MHC class-I restricted TCRalphabeta+ CD4- CD8- double negative T cells recognizing the gp100 antigen from a melanoma patient after gp100 vaccination.
    Voelkl S; Moore TV; Rehli M; Nishimura MI; Mackensen A; Fischer K
    Cancer Immunol Immunother; 2009 May; 58(5):709-18. PubMed ID: 18836718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of cytotoxic effector cells against human melanoma.
    Leong SP; Zhou YM; Granberry ME; Wang TF; Grogan TM; Spier C; White R; Mehta A; Lin AY
    Cancer Immunol Immunother; 1995 Jun; 40(6):397-409. PubMed ID: 7627996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphocytes from lymph nodes at different distances from human melanoma vary in their capacity to inhibit/enhance tumor cell growth in vitro.
    Farzad Z; McBride WH; Ogbechi H; Asnong-Holthoff C; Morton DL; Cochran AJ
    Melanoma Res; 1997 Aug; 7 Suppl 2():S59-65. PubMed ID: 9578418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of tumour-specific cytotoxic T-cell clones from histocompatibility leucocyte antigen-identical siblings of patients with melanoma.
    Gottlieb DJ; Li YC; Lionello I; Tanzarella S; Marangolo M; Bradstock KF; Russo V; Traversari C
    Br J Cancer; 2006 Jul; 95(2):181-8. PubMed ID: 16819544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells.
    Topalian SL; Rivoltini L; Mancini M; Ng J; Hartzman RJ; Rosenberg SA
    Int J Cancer; 1994 Jul; 58(1):69-79. PubMed ID: 7516926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma.
    Robbins PF; El-Gamil M; Li YF; Zeng G; Dudley M; Rosenberg SA
    J Immunol; 2002 Nov; 169(10):6036-47. PubMed ID: 12421991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specificity, T cell receptor diversity and activation requirements of CD4+ and CD8+ clones derived from human melanoma-infiltrating lymphocytes.
    Pandolfino MC; Viret C; Gervois N; Guilloux Y; Davodeau F; Diez E; Jotereau F
    Eur J Immunol; 1992 Jul; 22(7):1795-802. PubMed ID: 1623924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional analysis of tumor-specific Th cell responses detected in melanoma patients after dendritic cell-based immunotherapy.
    Schultz ES; Schuler-Thurner B; Stroobant V; Jenne L; Berger TG; Thielemanns K; van der Bruggen P; Schuler G
    J Immunol; 2004 Jan; 172(2):1304-10. PubMed ID: 14707109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human autoreactive (Th0) CD4(+) T-cell clones with cytolytic activity recognizing autologous activated T cells as the target.
    Kaneko T
    Hum Immunol; 2000 Aug; 61(8):780-8. PubMed ID: 10980388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of T cell clones derived from lymph nodes and lungs of Pseudomonas aeruginosa-susceptible and resistant mice following immunization with heat-killed bacteria.
    Kondratieva TK; Kobets NV; Khaidukov SV; Yeremeev VV; Lyadova IV; Apt AS; Tam MF; Stevenson MM
    Clin Exp Immunol; 2000 Aug; 121(2):275-82. PubMed ID: 10931142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovalbumin-specific, MHC class I-restricted, alpha beta-positive, Tc1 and Tc0 CD8+ T cell clones mediate the in vivo inhibition of rat IgE.
    MacAry PA; Holmes BJ; Kemeny DM
    J Immunol; 1998 Jan; 160(2):580-7. PubMed ID: 9551891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD4+ T cell clones isolated from human renal cell carcinoma possess the functional characteristics of Th2 helper cells.
    Schoof DD; Terashima Y; Peoples GE; Goedegebuure PS; Andrews JV; Richie JP; Eberlein TJ
    Cell Immunol; 1993 Aug; 150(1):114-23. PubMed ID: 8102084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
    Mortarini R; Piris A; Maurichi A; Molla A; Bersani I; Bono A; Bartoli C; Santinami M; Lombardo C; Ravagnani F; Cascinelli N; Parmiani G; Anichini A
    Cancer Res; 2003 May; 63(10):2535-45. PubMed ID: 12750277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary but not metastatic human melanomas expressing DR antigens stimulate autologous lymphocytes.
    Fossati G; Taramelli D; Balsari A; Bogdanovich G; Andreola S; Parmiani G
    Int J Cancer; 1984 May; 33(5):591-7. PubMed ID: 6233227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 193.